New Key Statistics Module, Z-Score and F-Score
AMEX:AIM Key Ratios
| Market Cap $ M | 12.58 |
| Enterprise Value $ M | 8.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.95 |
| Price/Sales | 49.35 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.47 |
| Beneish M-Score | -5.26 |
| 10-y EBITDA Growth Rate % | 43.10 |
| 5-y EBITDA Growth Rate % | 40.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.31 |
| EV-to-EBITDA | -0.32 |
| PEG | -- |
| Shares Outstanding M | 63.78 |
| Net Margin (%) | -12,594.21 |
| Operating Margin % | -14,695.26 |
| Pre-tax Margin (%) | -12,594.21 |
| Quick Ratio | 0.75 |
| Current Ratio | 0.75 |
| ROA % (ttm) | -129.02 |
| ROE % (ttm) | -256.33 |
| ROIC % (ttm) | -401.15 |
| Dividend Yield % | -- |
| Altman Z-Score | -48.59 |
AIM Number of Guru Trades
AIM Volume of Guru Trades
Gurus Latest Trades with AMEX:AIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:AIM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AIM ImmunoTech Inc Insider Transactions
No Available Data
News about AMEX:AIM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers